| [공지] |
2026년 학회 및 전시정보  |
관리자 |
2026.01.01 |
519 |
| 64 |
Dual-Platform Solution for Next-Generation CAR-T Development |
관리자 |
2026.09.01 |
201 |
| 63 |
[논문] Rapid receptor internalization potentiates CD7-targeted lipid nanoparticles for efficient mRNA delivery |
관리자 |
2026.08.31 |
126 |
| 62 |
Human IgG subclasses (IgG1, IgG2, IgG3, IgG4) |
관리자 |
2026.07.01 |
781 |
| 61 |
[Citation] Antigen-binding affinity is a key determinant of the durable antitumor activity of CD5 CAR-T cells |
관리자 |
2026.04.27 |
2,594 |
| 60 |
[Citation] Structural Insights into Modulation of Neurexin-Neuroligin Trans-synaptic Adhesion |
관리자 |
2026.04.20 |
356 |
| 59 |
[논문] A cell line development vector strategy for improved expression of a trispecific T-cell engager in CHO |
관리자 |
2026.04.06 |
357 |
| 58 |
[Citation] A therapeutic human antibody against the domain 4 of the Bacillus anthracis |
관리자 |
2026.03.26 |
408 |
| 57 |
[논문] B cell depletion in autoimmune diseae (In vivo CAR-T or T cell enagers) |
관리자 |
2026.03.18 |
381 |
| 56 |
[Technical Support] Engineering and reformatting your antibody from mAb to bsAb |
관리자 |
2026.03.10 |
354 |
| 55 |
[Citation] Blockade of Activin Receptor IIB Protects Arthritis Pathogenesis |
관리자 |
2026.03.02 |
361 |
| 54 |
[Citation] Exercise-induced CLCF1 attenuates age-related muscle and bone decline in mice |
관리자 |
2026.02.20 |
424 |
| 53 |
[논문] Antibodies to watch in 2026 |
관리자 |
2026.02.03 |
366 |
| 52 |
[Technical Support] The real-time kinetic and affinity data for bsAb or Fc engineering |
관리자 |
2026.01.23 |
361 |
| 51 |
[논문] Immunogenicity risk mitigation of therapeutic proteins with translational immunogenicity, |
관리자 |
2025.12.15 |
503 |
| 50 |
[Citation] Del-1, an Endogenous Inhibitor of TGF-β Activation, Attenuates Fibrosis |
관리자 |
2025.11.26 |
499 |
| 49 |
[논문] Developability considerations for bispecific and multispecific antibodies |
관리자 |
2025.11.18 |
380 |
| 48 |
[Citation] Endogenous DEL-1 restrains melanoma lung metastasis by limiting |
관리자 |
2025.11.11 |
425 |
| 47 |
[논문] Bispecific antibodies: advancing precision oncology |
관리자 |
2025.11.03 |
441 |
| 46 |
[Citation] Colony-stimulating factor 3 |
관리자 |
2025.10.17 |
548 |
| 45 |
[논문] Quantifying antibody binding techniques and therapeutic implications |
관리자 |
2025.08.18 |
957 |
